|
Market Closed -
Nasdaq
04:00:00 2026-08-27 pm EDT
|
5-day change | 1st Jan Change | ||
| 10.02 USD | 0.00% |
|
-0.69% | +62.93% |
| Aug. 14 | ImmuCell Corporation, Q2 2026 Earnings Call, Aug 14, 2026 | |
| Aug. 13 | ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq
ICCC 10.02 $
0.00%
31.87K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| ICCC | 10.02USD | 0.00% | 31.87K $ | |
CBOE
| ICCC | 9.890USD | -1.20% | 1.98K $ | |
|
Deutsche Boerse AG
| IUL | 8.500EUR | -0.58% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 10.44 | 11.72 | 11.21 |
| Spread/Res. | -4.02% | -14.51% | -10.62% |
| Spread/Supp. | +3.30% | +21.31% | +37.26% |
| Support | 9.7 | 8.26 | 7.3 |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
Select your edition
All financial news and data tailored to specific country editions
